These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 22071870)

  • 21. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.
    Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ
    J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breath biomarkers of liver cirrhosis.
    Dadamio J; Van den Velde S; Laleman W; Van Hee P; Coucke W; Nevens F; Quirynen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 905():17-22. PubMed ID: 22921634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The versatile use of exhaled volatile organic compounds in human health and disease.
    Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
    J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
    Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
    Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton transfer reaction-mass spectrometry applications in medical research.
    Herbig J; Amann A
    J Breath Res; 2009 Jun; 3(2):020201. PubMed ID: 21383455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.
    Allers M; Langejuergen J; Gaida A; Holz O; Schuchardt S; Hohlfeld JM; Zimmermann S
    J Breath Res; 2016 Apr; 10(2):026004. PubMed ID: 27058460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of metabolomic profiles obtained using chemical ionization and electron ionization MS in exhaled breath.
    Turner MA; Guallar-Hoyas C; Kent AL; Wilson ID; Thomas CL
    Bioanalysis; 2011 Dec; 3(24):2731-8. PubMed ID: 22185273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel extraction of volatile biomarkers from canine breath for gas chromatography-mass spectrometry.
    Dissanayake S; Lathan P; Mlsna T
    J Breath Res; 2012 Dec; 6(4):041001. PubMed ID: 22989995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
    Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
    Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exhaled breath analysis in adult patients with cystic fibrosis by real-time proton mass spectrometry.
    Mustafina M; Silantyev A; Krasovskiy S; Chernyak A; Naumenko Z; Suvorov A; Gognieva D; Abdullaev M; Bektimirova A; Bykova A; Dergacheva V; Betelin V; Kopylov P
    Clin Chim Acta; 2024 Jun; 560():119733. PubMed ID: 38777246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometric profile of exhaled breath--field study by PTR-MS.
    Moser B; Bodrogi F; Eibl G; Lechner M; Rieder J; Lirk P
    Respir Physiol Neurobiol; 2005 Feb; 145(2-3):295-300. PubMed ID: 15705543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton transfer reaction time-of-flight mass spectrometric measurements of volatile compounds contained in peppermint oil capsules of relevance to real-time pharmacokinetic breath studies.
    Malásková M; Henderson B; Chellayah PD; Ruzsanyi V; Mochalski P; Cristescu SM; Mayhew CA
    J Breath Res; 2019 Jul; 13(4):046009. PubMed ID: 31163413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.